$VGK Europe ETF FTSE Vanguard (VGK) 58.88 -0.47 (-0.79%)
$VGK
Europe ETF FTSE Vanguard (VGK)
58.88 -0.47 (-0.79%)
Past 5 Days
Date Open High Low Last Change % Change Volume
03/12/14 58.93 58.98 58.88 58.88 -0.47 -0.79% 200,471
03/11/14 59.61 59.87 59.31 59.35 -0.31 -0.52% 3,808,800
03/10/14 59.62 59.75 59.28 59.66 -0.43 -0.72% 5,014,500
03/07/14 60.34 60.38 59.76 60.09 -0.41 -0.68% 4,961,400
03/06/14 60.44 60.63 60.39 60.50 +0.62 +1.04% 2,618,900
Historical Highs and Lows
-- Period -- -- High -- -- Low -- -- Percent Change --
5-Day 60.63 on 03/06/14 58.88 on 03/12/14 -1.59% since 03/05/14
1-Month 60.63 on 03/06/14 58.16 on 02/13/14 +0.75% since 02/12/14
3-Month 60.63 on 03/06/14 55.00 on 02/03/14 +6.37% since 12/12/13
6-Month 60.63 on 03/06/14 53.31 on 10/09/13 +9.72% since 09/12/13
12-Month 60.63 on 03/06/14 46.85 on 06/24/13 +17.34% since 03/12/13
Year to Date 60.63 on 03/06/14 55.00 on 02/03/14 +0.22% since 12/31/13
New Highs and Lows
For The Last Made New High Percent From Made New Low Percent From
5-Day 1 time -2.80% 4 times +0.02%
1-Month 8 times -2.80% 1 time +1.32%
3-Month 19 times -2.80% 2 times +7.15%
6-Month 21 times -2.80% 2 times +10.54%
12-Month 35 times -2.80% 7 times +25.78%
Year to Date 14 times -2.80% 6 times +7.15%
Scroll down for more posts ▼
Top 10 Most Recent News Articles
End of an Era in Periodontology For those of us who have a stake in the world of dental technology, today hangs heavy. We talk about innovators, pioneers, and game-changers all the time, but Dr. Raymond A. Yukna wasn't just another name on that list - he was the list. The guy practically wrote the book on modern periodontal therapy. With his passing, we're not just saying...
Continue Reading
Breaking the 'Undruggable' Myth Out there in the trenches of drug discovery, this Medicilon and Revolution Medicines partnership has been stirring up some waves. Now, I ain't talking about your daily Wall Street hubbub, but a three-year grind that's led to something seriously noteworthy: turning the so-called 'undruggable' KRAS target into a real game-changer. Pan-KRAS...
Continue Reading
Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...
Continue Reading
Unpacking the Texas Auto Insurance Puzzle Ah, Texas. Land of vast highways and, apparently, some rather eyebrow-raising auto insurance complexities. Teri Cappadona from the Sapp Insurance Agency took to HelloNation to lay down the lowdown. If you're not up to speed, you might be blindsiding your bank account. We've all grumbled at those insurance bills, but understanding...
Continue Reading
MadaLuxe's Bold Step into Luxury Sleep Here's a twist in the luxury game: MadaLuxe Group has grabbed the reins of DUXIANA's North American distribution business. If you haven't run into this iconic Swedish brand yet, it's been peddling high-end beds for a good century. Yep, 100 years of Swedish craftsmanship now in the pocket of MadaLuxe. They didn't spill any beans on...
Continue Reading
Steering Towards Innovation in Kidney Care In the world of political accolades, real achievements sometimes get buried beneath the pomp. But when the largest kidney patient group in the nation—AAKP, decides to honor Senator Susan M. Collins, it's not just another pat on the back. This one's got substance galore. Collins, a heavyweight on the U.S. Senate Committee on...
Continue Reading
Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...
Continue Reading
Art Meets Animation: Glander's Inspiring Visit In the offbeat, winding world of creativity, Julian Glander's name rings some serious bells. This Pittsburgh-based powerhouse, known for his whimsical animations and illustrations, is heading to Rocky Mountain College of Art + Design (RMCAD) for the 2026/2027 Friction Series. It's happening November 10—pencil that in...
Continue Reading
Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...
Continue Reading
Big Copper Moves at La Verde: What's New? Look, when it comes to copper, Hot Chili Limited is throwing down some serious markers. You see, their La Verde project is turning into a hotbed of activity thanks to their latest drilling revelations. They've managed to confirm a second porphyry center, which is like finding another gold mine, except with copper. This essentially...
Continue Reading
Top 5 Most Recently Viewed Articles
SL Green Realty's Impressive Q4 Performance SL Green Realty (NYSE: SLG), a leading office real estate investment trust based in New York, has captured the market's attention with a remarkable surge in its share price, rising as much as 4.2% in premarket trading recently. This uptick follows the company's robust fourth quarter results, which exceeded analysts'...
Continue Reading
October Boot of the Month: The Paladin and Tinsley Chippewa Boots proudly presents its October Boot of the Month: the Paladin and Tinsley, both exceptional 8-inch Waterproof Insulated Steel Toe Loggers. These boots are designed to excel in tough work environments while providing the necessary protection, comfort, and performance that professionals need. Features of the...
Continue Reading
Omada Secures Investment to Enhance Identity Governance Solutions Omada A/S is excited to announce a transformative phase in its journey with the backing of existing investor GRO and new partner Kirk Kapital. This investment is set to enhance Omada's position as a leading provider of Identity Governance and Administration (IGA) software, enabling significant expansion and...
Continue Reading
Royalty Pharma Expands Its Royalty Portfolio Royalty Pharma plc (Nasdaq: RPRX) is set to enhance its standing in the biopharmaceutical industry by acquiring a synthetic royalty related to Geron Corporation’s RYTELO (imetelstat) for an upfront payment of $125 million. This acquisition underscores Royalty Pharma's commitment to advancing biopharmaceutical innovation and...
Continue Reading
Rocket Lab’s Anticipation for Third Quarter Results Announcement Rocket Lab Corporation (NASDAQ: RKLB), a prominent player in the launch services and space systems arena, has officially announced its plans for revealing third quarter financial results for the year 2025. This eagerly awaited event is set to take place following the closure of U.S. markets on a scheduled...
Continue Reading